Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawal
JavaScript is disabled for your browser. Some features of this site may not work without it.
Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawal
Document Type: Article
Version: Published version
Date:
2020
This document is associated with a Creative Common license
Citation:Lopez-Castillo D, March-Rodriguez A, Rodriguez-Vida A, Pujol RM, Segura S. Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawal. Acta Derm Venereol. 2020 Mar 12; 100(6): adv00079. DOI: 10.2340/00015555-3438